Matches in SemOpenAlex for { <https://semopenalex.org/work/W2291265108> ?p ?o ?g. }
- W2291265108 endingPage "44" @default.
- W2291265108 startingPage "36" @default.
- W2291265108 abstract "Aberrant ligand-independent G protein–coupled receptor constitutive activity has been implicated in the pathophysiology of a number of cancers. The adenosine A<sub>2B</sub> receptor (A<sub>2B</sub>AR) is dynamically upregulated under pathologic conditions associated with a hypoxic microenvironment, including solid tumors. This, in turn, may amplify ligand-independent A<sub>2B</sub>AR signal transduction. The contribution of A<sub>2B</sub>AR constitutive activity to disease progression is currently unknown yet of fundamental importance, as the preferred therapeutic modality for drugs designed to reduce A<sub>2B</sub>AR constitutive activity would be inverse agonism as opposed to neutral antagonism. The current study investigated A<sub>2B</sub>AR constitutive activity in a heterologous expression system and a native 22Rv1 human prostate cancer cell line exposed to hypoxic conditions (2% O<sub>2</sub>). The A<sub>2B</sub>AR inverse agonists, ZM241385 [4-(2-[7-amino-2-(2-furyl)[1,2,4]triazolo[2,3-<i>a</i>][1,3,5]triazin-5-ylamino]ethyl)phenol] or PSB-603 (8-(4-(4-(4-chlorophenyl)piperazide-1-sulfonyl)phenyl)-1-propylxanthine), mediated a concentration-dependent decrease in baseline cAMP levels in both cellular systems. Proliferation of multiple prostate cancer cell lines was also attenuated in the presence of PSB-603. Importantly, both the decrease in baseline cAMP accumulation and the reduction of proliferation were not influenced by the addition of adenosine deaminase, demonstrating that these effects are not dependent on stimulation of A<sub>2B</sub>ARs by the endogenous agonist adenosine. Our study is the first to reveal that wild-type human A<sub>2B</sub>ARs have high constitutive activity in both model and native cells. Furthermore, our findings demonstrate that this ligand-independent A<sub>2B</sub>AR constitutive activity is sufficient to promote prostate cancer cell proliferation in vitro. More broadly, A<sub>2B</sub>AR constitutive activity may have wider, currently unappreciated implications in pathologic conditions associated with a hypoxic microenvironment." @default.
- W2291265108 created "2016-06-24" @default.
- W2291265108 creator A5013247809 @default.
- W2291265108 creator A5015119508 @default.
- W2291265108 creator A5016689951 @default.
- W2291265108 creator A5019565246 @default.
- W2291265108 creator A5021271630 @default.
- W2291265108 creator A5077280255 @default.
- W2291265108 date "2016-01-20" @default.
- W2291265108 modified "2023-10-02" @default.
- W2291265108 title "Ligand-Independent Adenosine A2B Receptor Constitutive Activity as a Promoter of Prostate Cancer Cell Proliferation" @default.
- W2291265108 cites W122518273 @default.
- W2291265108 cites W1482654523 @default.
- W2291265108 cites W1493633378 @default.
- W2291265108 cites W1536524213 @default.
- W2291265108 cites W1581606222 @default.
- W2291265108 cites W1605956253 @default.
- W2291265108 cites W1916235480 @default.
- W2291265108 cites W1965554200 @default.
- W2291265108 cites W1965835906 @default.
- W2291265108 cites W1969444624 @default.
- W2291265108 cites W1970964820 @default.
- W2291265108 cites W1975454274 @default.
- W2291265108 cites W1989591424 @default.
- W2291265108 cites W1991512318 @default.
- W2291265108 cites W2001033076 @default.
- W2291265108 cites W2017658838 @default.
- W2291265108 cites W2023724239 @default.
- W2291265108 cites W2024773645 @default.
- W2291265108 cites W2044332972 @default.
- W2291265108 cites W2049886186 @default.
- W2291265108 cites W2052727988 @default.
- W2291265108 cites W2053968398 @default.
- W2291265108 cites W2062778364 @default.
- W2291265108 cites W2082083390 @default.
- W2291265108 cites W2089232549 @default.
- W2291265108 cites W2092117240 @default.
- W2291265108 cites W2092754405 @default.
- W2291265108 cites W2096098509 @default.
- W2291265108 cites W2099488023 @default.
- W2291265108 cites W2104707233 @default.
- W2291265108 cites W2107277218 @default.
- W2291265108 cites W2126431774 @default.
- W2291265108 cites W2131086952 @default.
- W2291265108 cites W2131609320 @default.
- W2291265108 cites W2131783439 @default.
- W2291265108 cites W2139526470 @default.
- W2291265108 cites W2140575551 @default.
- W2291265108 cites W2145736355 @default.
- W2291265108 cites W2168055235 @default.
- W2291265108 cites W2321635279 @default.
- W2291265108 cites W2336709108 @default.
- W2291265108 doi "https://doi.org/10.1124/jpet.115.230003" @default.
- W2291265108 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26791603" @default.
- W2291265108 hasPublicationYear "2016" @default.
- W2291265108 type Work @default.
- W2291265108 sameAs 2291265108 @default.
- W2291265108 citedByCount "47" @default.
- W2291265108 countsByYear W22912651082016 @default.
- W2291265108 countsByYear W22912651082017 @default.
- W2291265108 countsByYear W22912651082018 @default.
- W2291265108 countsByYear W22912651082019 @default.
- W2291265108 countsByYear W22912651082020 @default.
- W2291265108 countsByYear W22912651082021 @default.
- W2291265108 countsByYear W22912651082022 @default.
- W2291265108 countsByYear W22912651082023 @default.
- W2291265108 crossrefType "journal-article" @default.
- W2291265108 hasAuthorship W2291265108A5013247809 @default.
- W2291265108 hasAuthorship W2291265108A5015119508 @default.
- W2291265108 hasAuthorship W2291265108A5016689951 @default.
- W2291265108 hasAuthorship W2291265108A5019565246 @default.
- W2291265108 hasAuthorship W2291265108A5021271630 @default.
- W2291265108 hasAuthorship W2291265108A5077280255 @default.
- W2291265108 hasBestOaLocation W22912651081 @default.
- W2291265108 hasConcept C116569031 @default.
- W2291265108 hasConcept C121608353 @default.
- W2291265108 hasConcept C126322002 @default.
- W2291265108 hasConcept C134018914 @default.
- W2291265108 hasConcept C166342909 @default.
- W2291265108 hasConcept C170493617 @default.
- W2291265108 hasConcept C185592680 @default.
- W2291265108 hasConcept C2776885963 @default.
- W2291265108 hasConcept C2776991684 @default.
- W2291265108 hasConcept C2778938600 @default.
- W2291265108 hasConcept C2780192828 @default.
- W2291265108 hasConcept C502942594 @default.
- W2291265108 hasConcept C55493867 @default.
- W2291265108 hasConcept C62112901 @default.
- W2291265108 hasConcept C62478195 @default.
- W2291265108 hasConcept C67907053 @default.
- W2291265108 hasConcept C71924100 @default.
- W2291265108 hasConcept C86803240 @default.
- W2291265108 hasConcept C89951826 @default.
- W2291265108 hasConcept C98274493 @default.
- W2291265108 hasConceptScore W2291265108C116569031 @default.
- W2291265108 hasConceptScore W2291265108C121608353 @default.
- W2291265108 hasConceptScore W2291265108C126322002 @default.
- W2291265108 hasConceptScore W2291265108C134018914 @default.